• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Large owner Carlyle Group Inc.

    10/2/25 4:30:31 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Carlyle Group Inc.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW, SUITE 220 S

    (Street)
    WASHINGTON DC 20004-2505

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CommScope Holding Company, Inc. [ COMM ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    09/30/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Series A Convertible Preferred Stock (1) 09/30/2025 J(2) 17,343 (1) (1) Common Stock 630,653 (2) 1,278,653 I See Footnotes(3)(4)
    1. Name and Address of Reporting Person*
    Carlyle Group Inc.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW, SUITE 220 S

    (Street)
    WASHINGTON DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Carlyle Holdings I GP Inc.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Carlyle Holdings I GP Sub L.L.C.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Carlyle Holdings I L.P.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    CG Subsidiary Holdings L.L.C.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    TC Group, LLC

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    TC Group Sub L.P.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    TC Group VII S1, L.L.C.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    TC Group VII S1, L.P.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Carlyle Partners VII S1 Holdings, L.P.

    (Last) (First) (Middle)
    C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVE., NW,SUITE 220 S

    (Street)
    WASHINGTON, DC 20004-2505

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. The number of shares of Common Stock of the Issuer deliverable upon conversion of each share of Series A Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"), is initially equal to 36.3636 shares, subject to customary anti-dilution adjustments. The Preferred Stock is convertible at any time and has no stated maturity. The Preferred Stock will remain outstanding indefinitely unless converted, repurchased or redeemed by the Issuer. The Issuer may mandatorily convert the Preferred Stock into Common Stock at any time after the three-year anniversary of the issuance, if certain conditions are met.
    2. The reporting person received these shares of Series A Convertible Preferred Stock as a payment-in-kind dividend on the shares of Series A Convertible Preferred Stock owned on the dividend record date. Holders of the Series A Convertible Preferred Stock are entitled to a cumulative dividend at the rate of 5.5% per year, payable quarterly in arrears.
    3. Carlyle Partners VII S1 Holdings, L.P. is the record holder of the securities reported herein.
    4. The Carlyle Group Inc., which is a publicly traded entity listed on the Nasdaq, is the sole shareholder of Carlyle Holdings I GP Inc., which is the sole member of Carlyle Holdings I GP Sub L.L.C., which is the general partner of Carlyle Holdings I L.P., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the managing member of TC Group, L.L.C., which is the general partner of TC Group Sub L.P., which is the managing member of TC Group VII S1, L.L.C., which is the general partner of TC Group VII S1, L.P., which is the general partner of Carlyle Partners VII S1 Holdings, L.P. Accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by Carlyle Partners VII S1 Holdings, L.P. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein, if any.
    The Carlyle Group Inc., By: /s/ Anne Frederick, Corporate Secretary 10/02/2025
    Carlyle Holdings I GP Inc., By: /s/ Anne Frederick, Managing Director 10/02/2025
    Carlyle Holdings I GP Sub L.L.C., By: Carlyle Holdings I GP Inc., its sole member, By: /s/ Anne Frederick, Managing Director 10/02/2025
    Carlyle Holdings I L.P., By: /s/ Anne Frederick, Managing Director 10/02/2025
    CG Subsidiary Holdings L.L.C., By: /s/ Anne Frederick, Managing Director 10/02/2025
    TC Group, L.L.C., By: /s/ Anne Frederick, Managing Director 10/02/2025
    TC Group Sub L.P.,By: TC Group, L.L.C., its general partner, By: /s/ Anne Frederick, Managing Director 10/02/2025
    TC Group VII S1, L.L.C.,By: /s/ Jeremy W. Anderson, Vice President 10/02/2025
    TC Group VII S1, L.P., By: /s/ Jeremy W. Anderson, Vice President 10/02/2025
    Carlyle Partners VII S1 Holdings, L.P.,By: TC Group VII S1, L.P., its general partner,By: /s/ Jeremy W. Anderson, Vice President 10/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    8/6/2024$46.00 → $44.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    9/19/25 4:16:41 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 8-K filed by The Carlyle Group Inc.

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    9/16/25 8:12:26 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form FWP filed by The Carlyle Group Inc.

    FWP - Carlyle Group Inc. (0001527166) (Subject)

    9/16/25 5:03:31 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle Secured Lending, Inc. Prices Public Company Offering of $300 Million 5.750% Unsecured Notes Due 2031

    NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (NASDAQ:CGBD) (the "Company") today announced that it has priced an underwritten public offering of $300 million in aggregate principal amount of 5.750% unsecured notes due 2031 (the "Notes"). The Notes will mature on February 15, 2031 and may be redeemed in whole or in part at the Company's option at the applicable redemption price. The offering is expected to close on October 7, 2025, subject to customary closing conditions. The Company intends to use the net proceeds from this offering to repay outstanding debt including the Company's revolving credit facility (which the Company intends to use to repay its subsi

    9/30/25 5:01:04 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Acentra Health's Dr. Ryan Bosch Named a 2025 Innovator in Health Care by Washington Business Journal

    MCLEAN, Va., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company committed to accelerating better health outcomes for its clients and the populations they serve, today announced that its Chief Health and Informatics Officer, Ryan Bosch, MD, has been named a 2025 Innovator in Health Care by the Washington Business Journal. The annual award recognizes Greater Washington's top clinical and business leaders who are solving healthcare's biggest challenges through innovative technology, vision, talent, and care for the region's diverse population. A practicing internal medicine physician, U.S. Air Force veteran, and nationally recognized inf

    9/30/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Resonetics® Acquires Eden Holdings, Adding Injection Molding to its Capabilities

    Acquisition adds precision micro-molding, insert molding, and advanced machining and tooling to Resonetics' portfolio of precision manufacturing capabilities. NASHUA, N.H., Sept. 29, 2025 /PRNewswire/ -- Resonetics announced today that it has acquired Eden Holdings (Eden), comprising both Eden Manufacturing and Eden Tool, a precision manufacturer specializing in injection molding and micro machining solutions for critical medical devices. The acquisition adds micro-molding, insert-molding, and advanced machining and tooling, complementing Resonetics' established metal processing capabilities, while also expanding the Swiss machining and EDM machining offerings. These additions enhance Resone

    9/29/25 8:00:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Large owner Carlyle Group Inc.

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    10/2/25 4:30:31 PM ET
    $CG
    Investment Managers
    Finance

    Director Conway William E Jr gifted 2,000,000 shares, decreasing direct ownership by 7% to 26,999,644 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    9/5/25 5:05:14 PM ET
    $CG
    Investment Managers
    Finance

    Chief Operating Officer Lobue Lindsay was granted 496 shares, increasing direct ownership by 0.10% to 476,225 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    8/29/25 4:55:04 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by TD Cowen with a new price target

    TD Cowen upgraded Carlyle Group from Hold to Buy and set a new price target of $56.00

    5/14/25 8:48:54 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    New Medicaid Alliance to Tackle AI Safety and Standards Across States

    MCLEAN, Va., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better health outcomes for its clients and the populations they serve, today announced the launch of the Safe AI in Medicaid Alliance (SAMA), a collaborative initiative uniting Medicaid leaders, policy experts, and technology innovators to develop safe and responsible Medicaid-focused frameworks for artificial intelligence (AI) adoption and use. Created with input and participation from the Washington State Health Care Authority (HCA), the Arizona Health Care Cost Containment System (AHCCCS), Amazon Web Services (AWS), McKinsey & Co., Arcadia, an

    9/9/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names Marnie Keogh as Senior Vice President of Marketing

    MCLEAN, Va., July 21, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Marnie Keogh has joined the company as Senior Vice President of Marketing. In this role, Keogh will lead the company's integrated marketing strategy, driving initiatives across brand development, digital marketing, thought leadership, and go-to-market campaigns. "Marnie brings a distinguished career in healthcare marketing and communications, with a proven ability to drive brand transformation, operational excellence, and digit

    7/21/25 9:47:00 AM ET
    $CG
    Investment Managers
    Finance

    SS&C Technologies to Acquire Calastone

    SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) today announced a definitive agreement to acquire Calastone, the largest global funds network and leading provider of technology solutions to the wealth and asset management industries, from global investment firm Carlyle. The purchase price is approximately £766 million (approximately US $1.03 billion), subject to certain adjustments. Headquartered in London, Calastone operates the largest global funds network, connecting more than 4,500 of the world's leading financial organizations across 57 markets. The acquisition is expected to close in Q4 2025, subject to regulatory approvals. SS&C expects the acquisition to be accretive within 12 mont

    7/21/25 4:00:00 AM ET
    $CG
    $SSNC
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CG
    Financials

    Live finance-specific insights

    View All

    Resonetics® Acquires Eden Holdings, Adding Injection Molding to its Capabilities

    Acquisition adds precision micro-molding, insert molding, and advanced machining and tooling to Resonetics' portfolio of precision manufacturing capabilities. NASHUA, N.H., Sept. 29, 2025 /PRNewswire/ -- Resonetics announced today that it has acquired Eden Holdings (Eden), comprising both Eden Manufacturing and Eden Tool, a precision manufacturer specializing in injection molding and micro machining solutions for critical medical devices. The acquisition adds micro-molding, insert-molding, and advanced machining and tooling, complementing Resonetics' established metal processing capabilities, while also expanding the Swiss machining and EDM machining offerings. These additions enhance Resone

    9/29/25 8:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Prices $800 Million Senior Notes Offering

    WASHINGTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) priced its offering of $800 million aggregate principal amount of 5.050% senior notes due 2035. The notes will be fully and unconditionally guaranteed by Carlyle's indirect subsidiaries Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C. The offering is expected to close on September 19, 2025, subject to customary closing conditions. Carlyle intends to use the net proceeds from the sale of the notes for general corporate purposes. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC

    9/16/25 4:56:00 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Announces Senior Notes Offering

    WASHINGTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) today announced its intention to offer, subject to market and other conditions, senior notes. The notes will be fully and unconditionally guaranteed by Carlyle's indirect subsidiaries Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C. Carlyle intends to use the net proceeds from the sale of the notes for general corporate purposes. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC , J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering. The off

    9/16/25 8:52:17 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance